RB Capital Management LLC increased its stake in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 4.3% in the 2nd quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 4,138 shares of the pharmacy operator’s stock after purchasing an additional 169 shares during the quarter. RB Capital Management LLC’s holdings in Walgreens Boots Alliance were worth $324,000 as of its most recent filing with the SEC.

Several other hedge funds also recently bought and sold shares of the stock. Atria Investments LLC boosted its holdings in shares of Walgreens Boots Alliance by 23.7% during the second quarter. Atria Investments LLC now owns 24,079 shares of the pharmacy operator’s stock worth $1,886,000 after purchasing an additional 4,614 shares during the period. Koshinski Asset Management Inc. boosted its holdings in shares of Walgreens Boots Alliance by 16.6% during the second quarter. Koshinski Asset Management Inc. now owns 10,624 shares of the pharmacy operator’s stock worth $832,000 after purchasing an additional 1,515 shares during the period. City Holding Co. boosted its holdings in shares of Walgreens Boots Alliance by 3.2% during the second quarter. City Holding Co. now owns 29,990 shares of the pharmacy operator’s stock worth $2,348,000 after purchasing an additional 930 shares during the period. Capital One National Association boosted its holdings in shares of Walgreens Boots Alliance by 11.6% during the second quarter. Capital One National Association now owns 3,654 shares of the pharmacy operator’s stock worth $286,000 after purchasing an additional 379 shares during the period. Finally, Stock Yards Bank & Trust Co. boosted its holdings in shares of Walgreens Boots Alliance by 2.4% during the second quarter. Stock Yards Bank & Trust Co. now owns 25,628 shares of the pharmacy operator’s stock worth $2,007,000 after purchasing an additional 600 shares during the period. Institutional investors and hedge funds own 60.16% of the company’s stock.

Several analysts recently commented on WBA shares. Needham & Company LLC upgraded shares of Walgreens Boots Alliance from a “hold” rating to a “buy” rating and set a $94.00 price target for the company in a report on Friday, June 30th. Pivotal Research set a $85.00 price target on shares of Walgreens Boots Alliance and gave the stock a “hold” rating in a report on Sunday, July 2nd. Zacks Investment Research cut shares of Walgreens Boots Alliance from a “hold” rating to a “sell” rating in a report on Wednesday, June 14th. BidaskClub upgraded shares of Walgreens Boots Alliance from a “sell” rating to a “hold” rating in a report on Wednesday, August 30th. Finally, Goldman Sachs Group, Inc. (The) restated a “neutral” rating and set a $77.00 price target (down from $89.00) on shares of Walgreens Boots Alliance in a report on Wednesday, June 28th. Two equities research analysts have rated the stock with a sell rating, three have given a hold rating and fourteen have assigned a buy rating to the company’s stock. The company currently has a consensus rating of “Buy” and an average price target of $91.81.

Walgreens Boots Alliance, Inc. (NASDAQ WBA) traded up 0.61% during trading on Monday, hitting $83.00. 2,000,584 shares of the stock were exchanged. The firm’s 50 day moving average price is $81.26 and its 200-day moving average price is $81.99. Walgreens Boots Alliance, Inc. has a 1-year low of $75.18 and a 1-year high of $88.00. The stock has a market cap of $88.82 billion, a price-to-earnings ratio of 20.96 and a beta of 1.26.

Walgreens Boots Alliance (NASDAQ:WBA) last released its quarterly earnings data on Thursday, June 29th. The pharmacy operator reported $1.33 EPS for the quarter, beating the consensus estimate of $1.30 by $0.03. The company had revenue of $30.12 billion during the quarter, compared to the consensus estimate of $29.72 billion. Walgreens Boots Alliance had a return on equity of 17.34% and a net margin of 3.69%. The firm’s revenue for the quarter was up 2.1% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $1.18 EPS. On average, analysts anticipate that Walgreens Boots Alliance, Inc. will post $5.00 EPS for the current year.

Walgreens Boots Alliance announced that its board has authorized a share repurchase plan on Thursday, June 29th that allows the company to repurchase $5.00 billion in outstanding shares. This repurchase authorization allows the pharmacy operator to buy up to 5.9% of its stock through open market purchases. Stock repurchase plans are often an indication that the company’s management believes its shares are undervalued.

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, September 12th. Stockholders of record on Friday, August 18th were issued a $0.40 dividend. This represents a $1.60 annualized dividend and a dividend yield of 1.92%. The ex-dividend date was Wednesday, August 16th. This is an increase from Walgreens Boots Alliance’s previous quarterly dividend of $0.38. Walgreens Boots Alliance’s dividend payout ratio is presently 40.30%.

In other news, Director William C. Foote sold 2,736 shares of the stock in a transaction that occurred on Tuesday, July 25th. The stock was sold at an average price of $79.79, for a total value of $218,305.44. Following the completion of the sale, the director now owns 19,151 shares of the company’s stock, valued at approximately $1,528,058.29. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Corporate insiders own 13.50% of the company’s stock.

WARNING: This piece was first reported by The Cerbat Gem and is owned by of The Cerbat Gem. If you are reading this piece on another domain, it was illegally copied and reposted in violation of United States and international copyright and trademark legislation. The correct version of this piece can be accessed at https://www.thecerbatgem.com/2017/09/18/rb-capital-management-llc-boosts-position-in-walgreens-boots-alliance-inc-wba.html.

Walgreens Boots Alliance Company Profile

Walgreens Boots Alliance, Inc (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led, health and wellbeing enterprise. Walgreens Boots Alliance operates through three divisions, including Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Company’s products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand).

Want to see what other hedge funds are holding WBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Walgreens Boots Alliance, Inc. (NASDAQ:WBA).

Institutional Ownership by Quarter for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Stock Ratings for Walgreens Boots Alliance Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance Inc. and related stocks with our FREE daily email newsletter.